-
1
Impact of HER2 Expression on the Prognosis of Muscle-Invasive Bladder Cancer Patients Treated with Bladder-Preservation Comprehensive Therapy
Published 2025-01-01Subjects: Get full text
Article -
2
Feasibility of enzalutamide on patients with recurrent non-muscle-invasive bladder cancer with marker tumors: phase I study
Published 2025-01-01Subjects: “…Non-muscle invasive bladder cancer…”
Get full text
Article -
3
Nucleotide variation in Foxp3 gene and prognosis of bladder cancer: a case-control study
Published 2025-01-01Subjects: Get full text
Article -
4
Trimodal organ‑preserving treatment of muscle‑invasive bladder cancer
Published 2023-03-01Subjects: “…muscle-invasive bladder cancer…”
Get full text
Article -
5
Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
Published 2024-11-01Subjects: Get full text
Article -
6
Risk factors for lymphatic leakage following radical cystectomy and pelvic lymph node dissection in patients with muscle-invasive bladder cancer
Published 2025-01-01Subjects: Get full text
Article -
7
Prognostic evaluation of non-muscle invasive bladder cancer with P-CRP and its nomogram
Published 2025-02-01Subjects: “…non-muscle invasive bladder cancer…”
Get full text
Article -
8
Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
Published 2024-11-01Subjects: Get full text
Article -
9
-
10
Comparison of BCG Tokyo172 Strain Induction Therapy Between Low Dose and Standard Dose for Non-Muscle Invasive Bladder Cancer: Intravesical Instillation of BCG Tokyo172 Strain
Published 2025-01-01Subjects: “…non-muscle invasive bladder cancer…”
Get full text
Article -
11
Clinical and molecular response to alpha1‐oleate treatment in patients with bladder cancer
Published 2024-09-01Subjects: Get full text
Article -
12
A novel bladder cancer surveillance schedule using bladder Cx for patients on annual surveillance
Published 2025-01-01Subjects: Get full text
Article